AR012426A1 - Un compuesto de indazol amida, un procedimiento para prepararlo, compuestos intermediarios, y una composicion farmaceutica que comprende dicho compuesto de indazol amida. - Google Patents

Un compuesto de indazol amida, un procedimiento para prepararlo, compuestos intermediarios, y una composicion farmaceutica que comprende dicho compuesto de indazol amida.

Info

Publication number
AR012426A1
AR012426A1 ARP980101721A ARP980101721A AR012426A1 AR 012426 A1 AR012426 A1 AR 012426A1 AR P980101721 A ARP980101721 A AR P980101721A AR P980101721 A ARP980101721 A AR P980101721A AR 012426 A1 AR012426 A1 AR 012426A1
Authority
AR
Argentina
Prior art keywords
compound
amida
indazol
3alkyl
hydrogen
Prior art date
Application number
ARP980101721A
Other languages
English (en)
Spanish (es)
Inventor
Alisi Alessandra
Brufani Mario
Cazzolla Nicola
Giannangeli Marilena
Pinza Mario
Original Assignee
Angelini Ricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angelini Ricerche Spa filed Critical Angelini Ricerche Spa
Publication of AR012426A1 publication Critical patent/AR012426A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Paints Or Removers (AREA)
ARP980101721A 1997-04-15 1998-04-15 Un compuesto de indazol amida, un procedimiento para prepararlo, compuestos intermediarios, y una composicion farmaceutica que comprende dicho compuesto de indazol amida. AR012426A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI000867A IT1291569B1 (it) 1997-04-15 1997-04-15 Indazolammidi come agenti serotoninergici

Publications (1)

Publication Number Publication Date
AR012426A1 true AR012426A1 (es) 2000-10-18

Family

ID=11376888

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980101721A AR012426A1 (es) 1997-04-15 1998-04-15 Un compuesto de indazol amida, un procedimiento para prepararlo, compuestos intermediarios, y una composicion farmaceutica que comprende dicho compuesto de indazol amida.

Country Status (26)

Country Link
US (1) US6197769B1 (cg-RX-API-DMAC7.html)
EP (1) EP0975623B1 (cg-RX-API-DMAC7.html)
JP (2) JP4578581B2 (cg-RX-API-DMAC7.html)
KR (1) KR100563867B1 (cg-RX-API-DMAC7.html)
CN (1) CN1318416C (cg-RX-API-DMAC7.html)
AR (1) AR012426A1 (cg-RX-API-DMAC7.html)
AT (1) ATE219490T1 (cg-RX-API-DMAC7.html)
AU (1) AU740360B2 (cg-RX-API-DMAC7.html)
BG (1) BG64006B1 (cg-RX-API-DMAC7.html)
CA (1) CA2286870C (cg-RX-API-DMAC7.html)
CZ (1) CZ295190B6 (cg-RX-API-DMAC7.html)
DE (1) DE69806141T2 (cg-RX-API-DMAC7.html)
DK (1) DK0975623T3 (cg-RX-API-DMAC7.html)
EA (1) EA002352B1 (cg-RX-API-DMAC7.html)
ES (1) ES2178205T3 (cg-RX-API-DMAC7.html)
GE (1) GEP20022654B (cg-RX-API-DMAC7.html)
HU (1) HU227973B1 (cg-RX-API-DMAC7.html)
IL (1) IL132127A (cg-RX-API-DMAC7.html)
IT (1) IT1291569B1 (cg-RX-API-DMAC7.html)
PL (1) PL193308B1 (cg-RX-API-DMAC7.html)
PT (1) PT975623E (cg-RX-API-DMAC7.html)
SK (1) SK284731B6 (cg-RX-API-DMAC7.html)
TR (1) TR199902546T2 (cg-RX-API-DMAC7.html)
UA (1) UA58550C2 (cg-RX-API-DMAC7.html)
WO (1) WO1998046589A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA982926B (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1291569B1 (it) * 1997-04-15 1999-01-11 Angelini Ricerche Spa Indazolammidi come agenti serotoninergici
MXPA03007621A (es) 2001-02-23 2003-12-04 Merck & Co Inc Antagonistas nr2b de n-metil-d-aspartato no arilheterociclicos n-sustituidos.
EP1390034A4 (en) * 2001-04-03 2005-07-13 Merck & Co Inc N-SUBSTITUTED NONARYL HETEROCYCLO AMIDYL-NMDA / NR2B ANTAGONISTS
ITMI20030287A1 (it) 2003-02-18 2004-08-19 Acraf Indazolammidi dotate di attivita' analgesica metodo, per
ITMI20030972A1 (it) 2003-05-15 2004-11-16 Acraf Indazolo dotato di attivita' analgesica, metodo per prepararlo e composizione farmaceutica che lo comprende.
ITMI20031468A1 (it) * 2003-07-18 2005-01-19 Acraf Farmaco ativo nel dolore neuropatico
TW200533348A (en) * 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
US7728006B2 (en) * 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
TWI351282B (en) 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
US8309575B2 (en) 2004-04-07 2012-11-13 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
DE602005016446D1 (de) * 2004-11-05 2009-10-15 Theravance Inc 5-HT4-Rezeptoragonistenverbindungen
DE602005014566D1 (de) * 2004-11-05 2009-07-02 Theravance Inc Chinolinon-carboxamid-verbindungen
ATE469897T1 (de) * 2004-12-22 2010-06-15 Theravance Inc Indazolcarbonsäureamidverbindungen
US20060183901A1 (en) * 2005-02-17 2006-08-17 Theravance, Inc. Crystalline form of an indazole-carboxamide compound
BRPI0608392A2 (pt) * 2005-03-02 2009-12-29 Theravance Inc compostos de quinolinona como agonistas do receptor 5-ht4
ITMI20062230A1 (it) * 2006-11-22 2008-05-23 Acraf Composto 2-alchil-indazolico procedimento per preparalo e composizione farmaceutica che lo comprende
UA99927C2 (uk) * 2007-11-12 2012-10-25 Ацьенде Кимике Риуните Анджелини Франческо А.Чи.Р.А.Ф. С.П.А. Медикамент, який є активним при невропатичному болі
US8377968B2 (en) * 2008-06-02 2013-02-19 Zalicus Pharmaceuticals, Ltd. N-piperidinyl acetamide derivatives as calcium channel blockers
CA2833507A1 (en) * 2011-06-07 2012-12-13 Dainippon Sumitomo Pharma Co., Ltd. Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof
WO2013124169A1 (en) * 2012-02-21 2013-08-29 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Use of 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors
EA024939B1 (ru) * 2012-02-21 2016-11-30 Ацьенде Кимике Рьюните Анджелини Франческо А.К.Р.А.Ф. С.П.А. 1h-индазол-3-карбоксамидные соединения в качестве ингибиторов гликогенсинтазы киназы 3-бета
WO2014134306A1 (en) 2013-03-01 2014-09-04 Zalicus Pharmaceuticals, Ltd. Heterocyclic inhibitors of the sodium channel
WO2021007487A1 (en) 2019-07-11 2021-01-14 Praxis Precision Medicines, Inc. Formulations of t-type calcium channel modulators and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9103862D0 (en) * 1991-02-25 1991-04-10 Glaxo Group Ltd Chemical compounds
NZ243993A (en) * 1991-08-20 1994-10-26 Smithkline Beecham Plc Pharmaceutical compositions having 5-ht4 receptor antagonist activity and selected compounds having such activity
IL117438A (en) * 1995-03-16 2001-12-23 Lilly Co Eli Indazolecarboxamides, their preparation and pharmaceutical compositions containing them
WO1996038420A1 (en) * 1995-05-31 1996-12-05 Nisshin Flour Milling Co., Ltd. Indazole derivatives having monocyclic amino group
IT1291569B1 (it) * 1997-04-15 1999-01-11 Angelini Ricerche Spa Indazolammidi come agenti serotoninergici

Also Published As

Publication number Publication date
JP5237324B2 (ja) 2013-07-17
EA199900935A1 (ru) 2000-04-24
HK1027811A1 (en) 2001-01-23
SK284731B6 (sk) 2005-10-06
HUP0002057A2 (hu) 2001-04-28
EP0975623B1 (en) 2002-06-19
WO1998046589A2 (en) 1998-10-22
BG64006B1 (bg) 2003-09-30
KR20010006120A (ko) 2001-01-26
HU227973B1 (hu) 2012-07-30
ITMI970867A1 (it) 1998-10-15
CZ362599A3 (cs) 2000-04-12
DE69806141T2 (de) 2003-01-30
AU740360B2 (en) 2001-11-01
US6197769B1 (en) 2001-03-06
IL132127A (en) 2005-06-19
CA2286870C (en) 2007-05-22
DK0975623T3 (da) 2002-10-14
JP2010195813A (ja) 2010-09-09
EA002352B1 (ru) 2002-04-25
KR100563867B1 (ko) 2006-03-24
IT1291569B1 (it) 1999-01-11
PT975623E (pt) 2002-10-31
AU7215998A (en) 1998-11-11
UA58550C2 (uk) 2003-08-15
SK142399A3 (en) 2000-08-14
EP0975623A2 (en) 2000-02-02
ATE219490T1 (de) 2002-07-15
DE69806141D1 (de) 2002-07-25
PL193308B1 (pl) 2007-01-31
CZ295190B6 (cs) 2005-06-15
WO1998046589A3 (en) 1999-01-28
CN1252798A (zh) 2000-05-10
JP4578581B2 (ja) 2010-11-10
IL132127A0 (en) 2001-03-19
JP2001518906A (ja) 2001-10-16
GEP20022654B (en) 2002-03-25
ES2178205T3 (es) 2002-12-16
CN1318416C (zh) 2007-05-30
PL336348A1 (en) 2000-06-19
CA2286870A1 (en) 1998-10-22
ZA982926B (en) 1998-10-09
TR199902546T2 (xx) 2000-05-22
HUP0002057A3 (en) 2002-01-28
BG103863A (en) 2000-07-31

Similar Documents

Publication Publication Date Title
AR009413A1 (es) Un compuesto, el cual es un derivado de distamicina benzoheterociclico, su utilizacion, un procedimiento para producirlo y una composicionfarmaceutica que lo comprende
ES2062395T3 (es) Nuevos compuestos de bencimidazol y su uso.
ES2113368T3 (es) Antagonistas de serotonina.
PE20050130A1 (es) Compuestos organicos
PE2799A1 (es) Lactamas e imidas heterociclicas de aralquilo y aralquilideno
ES2058292T3 (es) Derivados de indol.
ES2189330T3 (es) Derivados heterociclicos n6 de la adenosina sustituidos.
AR018917A1 (es) Compuestos derivados de adenosina que son agonistas en el receptor adenosina a1, proceso para su preparacion, composiciones farmaceuticas que los contienen.
ES2149215T3 (es) Bencilaminoquinuclidinas sustituidas como antagonistas de la sustancia p.
PE20020720A1 (es) Derivados benzimidazol y piridilimidazol como ligandos para receptores gabaa
AR029216A1 (es) Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento
AR019427A1 (es) Compuestos heterociclicos como inhibidores de enzimas de rotamasa, procedimiento para su preparacion, su uso para la preparacion de medicamentos, composiciones farmaceuticas y compuestos intermediarios utiles para su preparacion
ES2178205T3 (es) Compuestos amida indazol como agentes serotoninergicos.
MX9304524A (es) Nuevos derivados de indol y composiciones que los contienen.
AR035153A1 (es) Derivados de carboxamidas y cetonas de dihidrobenzodioxina
ES2065755T3 (es) Derivados de 3-aminopiridacinas activos sobre el sistema nervioso central.
PE20010647A1 (es) Moduladores de receptores de retinoide x (rxr) con perfil farmacologico mejorado
MX9602979A (es) Compuestos heterociclicos terapeuticos.
PE20081781A1 (es) Agonistas de adrenoreceptores alfa2c funcionalmente selectivos
PE20040682A1 (es) Derivados de ciclobutano como antagonistas de nk1
AR008621A1 (es) Un compuesto derivado de amina succinica, un procedimiento para llevar a cabo su preparacion y una composicion farmaceutica que comprende dichocompuesto
PE20021018A1 (es) DERIVADOS DE ß - CARBOLINA
ES2090024T3 (es) Compuestos de cefemo y procedimientos para su preparacion.
AR024840A1 (es) Compuestos de 5ht1 para terapia antidepresiva; composiciones farmaceuticas y su uso en la preparacion de medicamentos.
MX168469B (es) Procedimiento para la preparacion de derivados aminoalcoholes acilados

Legal Events

Date Code Title Description
FG Grant, registration
FG Grant, registration